Dr Trevor Bachmeyer · Video summary
Retatrutide, Pregnancy and Breastfeeding - Dr Trevor Bachmeyer
Dr. Bachmeyer strongly advises against using Retatrutide during pregnancy and breastfeeding due to its profound and potentially permanent negative impacts on fetal and infant development, metabolism, and long-term health.
Watch on YouTube ↗Key takeaways
- 🎯Retatrutide's active metabolites remain in the system for weeks, retaining significant biological activity and can cross the placenta and enter breast milk, affecting fetal and infant development.11:16
- 💡Pregnancy involves a deliberate biological shift towards insulin resistance to partition nutrients to the fetus; Retatrutide's action of increasing insulin sensitivity directly counteracts this, potentially impairing fetal growth.13:15
- 💡Retatrutide's appetite suppression significantly reduces caloric intake, which is detrimental during pregnancy when caloric needs increase, leading to potential fetal growth restriction and developmental abnormalities.14:13
- 💡The drug's effect on glucagon receptors can lead to maternal hyperglycemia, increasing the risk of fetal hyperinsulinemia, macrosomia, and neonatal hypoglycemia, with long-term metabolic consequences.15:19
- 💡Retatrutide disrupts the natural slowing of gastric emptying during pregnancy, exacerbating nausea and vomiting and leading to malabsorption of crucial nutrients, harming both mother and fetus.17:16
- 💡Receptors for GLP-1, GIP, and glucagon are present in fetal neuronal, pancreatic, and GI tissues; Retatrutide's activation of these receptors can cause permanent changes to neural architecture and function, and lead to fetal beta-cell dysfunction.18:36
Chapters
- 0:00🎯 Introduction and purpose
- 0:34🎯 Risks of Reatride during pregnancy
- 10:02🎯 Pharmacokinetics and metabolite persistence
- 18:52🎯 Impact on fetal development
- 21:14🎯 Breastfeeding concerns
- 25:28🎯 Effects on pregnancy physiology
- 33:15🎯 Long-term consequences for children
- 33:50🎯 Biological purpose of pregnancy and breastfeeding
- 35:36🎯 Call to action and final message
The digest
High Level Overview
Retatrutide, a potent GLP-1, GIP, and glucagon receptor agonist, is being widely promoted as a breakthrough weight loss drug. However, extensive evidence and expert analysis highlight severe risks when this drug is used during pregnancy and breastfeeding. This episode provides a detailed biological and clinical explanation of why retatrutide use in these critical developmental windows poses dangerous, long-term consequences for fetal and infant health. The content is essential for healthcare providers, pregnant or breastfeeding women, and anyone interested in understanding the profound developmental risks associated with retatrutide exposure.
Keep reading in The Digest
The full 5-minute article, 8 more sections, and every new episode from Dr Trevor Bachmeyer and the creators you follow.
- Understanding Retatrutide and Its Mechanisms
- Duration and Persistence of Retatrutide in the Body
- Critical Metabolic and Hormonal Disruptions During Pregnancy
- Impact on Fetal Development
- Risks to Nursing Infants Through Breast Milk Exposure
- The One Chance at Optimal Development
- Practical Implications and Takeaways
- Action-Oriented Summary
More from Dr Trevor Bachmeyer
The Endogenous GH Protocol Every Biohacker Needs to Know - Dr Trevor Bachmeyer
Unlock peak health and longevity by optimizing your body's endogenous growth hormone (GH) production, not by exogenous injection. Learn the powerful peptide stack and nutrient protocols.
STOP Combining Retatrutide and Tirzepatide - Dr Trevor Bachmeyer
Avoid stacking Retatrutide and Tirzepatide due to severe metabolic damage, organ harm, and permanent receptor desensitization, opting instead for a synergistic, non-contradictory approach.
KPV and TB500N vs Cholesterol, AFib and Heart Disease - Dr Trevor Bachmeyer
Cardiovascular disease is driven by chronic inflammation, not cholesterol. KPV resolves inflammation, while TB500 rebuilds damaged heart tissue, offering cardiac regeneration.
Grave's Disease and How to Reverse It - Dr Trevor Bachmeyer
Graves' disease is not a thyroid issue but a systemic inflammatory cascade stemming from immune dysregulation, reversible by addressing root causes like gut health and nervous system balance.